Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
Daniel Edmonston(Duke University), Jordana B. Cohen(University of Pennsylvania), Andrew M. South(Kidney Research UK), Matthew A. Sparks(Duke University)
Cited by 18
Related Papers
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
|Nature Reviews Nephrology|2020|292
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
|Nature Reviews Nephrology|2019|239
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
|American Journal of Kidney Diseases|2020|234
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|224
FGF23 and klotho at the intersection of kidney and cardiovascular disease
|Nature Reviews Cardiology|2023|116